Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Polio Vaccine as Potential Protection Against COVID-19: A Cluster-randomised Trial in Guinea-Bissau

NCT04445428 is registered in ClinicalTrials.gov with Bandim Health Project as lead sponsor.

NCT NCT04445428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04445428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Polio Vaccine as Potential Protection Against COVID-19: A Cluster-randomised Trial in Guinea-Bissau
Lead sponsor
Bandim Health Project
Phase
Phase 4
Overall status
Completed
Start date
July 15, 2020
Completion date
June 15, 2022
Enrollment
3,729 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid, morbidity, mortality, non-specific effects of vaccines, poliovirus vaccine, oral